Table of Content


Table of Contents
Introduction
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kise Receptor Type 2 or TrkB Tyrosine Kise or Tropomyosin Related Kise B or NTRK2 or EC 2.7.10.1) - Overview
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kise Receptor Type 2 or TrkB Tyrosine Kise or Tropomyosin Related Kise B or NTRK2 or EC 2.7.10.1) - Therapeutics Development
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kise Receptor Type 2 or TrkB Tyrosine Kise or Tropomyosin Related Kise B or NTRK2 or EC 2.7.10.1) - Therapeutics Assessment
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kise Receptor Type 2 or TrkB Tyrosine Kise or Tropomyosin Related Kise B or NTRK2 or EC 2.7.10.1) - Companies Involved in Therapeutics Development
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kise Receptor Type 2 or TrkB Tyrosine Kise or Tropomyosin Related Kise B or NTRK2 or EC 2.7.10.1) - Drug Profiles
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kise Receptor Type 2 or TrkB Tyrosine Kise or Tropomyosin Related Kise B or NTRK2 or EC 2.7.10.1) - Dormant Products
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kise Receptor Type 2 or TrkB Tyrosine Kise or Tropomyosin Related Kise B or NTRK2 or EC 2.7.10.1) - Discontinued Products
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kise Receptor Type 2 or TrkB Tyrosine Kise or Tropomyosin Related Kise B or NTRK2 or EC 2.7.10.1) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development by Stage of Development, H1 2019
Number of Products under Development by Therapy Areas, H1 2019
Number of Products under Development by Top 10 Indications, H1 2019
Number of Products by Mechanism of Actions, H1 2019
Number of Products by Stage and Mechanism of Actions, H1 2019
Number of Products by Routes of Administration, H1 2019
Number of Products by Stage and Routes of Administration, H1 2019
Number of Products by Molecule Types, H1 2019
Number of Products by Stage and Top 10 Molecule Types, H1 2019


List of Tables


Number of Products under Development by Stage of Development, H1 2019
Number of Products under Development by Therapy Areas, H1 2019
Number of Products under Development by Indications, H1 2019
Number of Products under Development by Indications, H1 2019 (Contd..1), H1 2019
Number of Products under Development by Indications, H1 2019 (Contd..2), H1 2019
Number of Products under Development by Indications, H1 2019 (Contd..3), H1 2019
Number of Products under Development by Indications, H1 2019 (Contd..4), H1 2019
Number of Products under Development by Companies, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Companies, H1 2019 (Contd..1), H1 2019
Products under Development by Companies, H1 2019 (Contd..2), H1 2019
Products under Development by Companies, H1 2019 (Contd..3), H1 2019
Products under Development by Companies, H1 2019 (Contd..4), H1 2019
Products under Development by Companies, H1 2019 (Contd..5), H1 2019
Products under Development by Companies, H1 2019 (Contd..6), H1 2019
Number of Products under Investigation by Universities/Institutes, H1 2019
Products under Investigation by Universities/Institutes, H1 2019
Number of Products by Stage and Mechanism of Actions, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Pipeline by Addex Therapeutics Ltd, H1 2019
Pipeline by AlzeCure Pharma AB, H1 2019
Pipeline by AnHeart Therapeutics Inc, H1 2019
Pipeline by Bayer AG, H1 2019
Pipeline by Boehringer Ingelheim GmbH, H1 2019
Pipeline by Celon Pharma SA, H1 2019
Pipeline by Chronos Therapeutics Ltd, H1 2019
Pipeline by Chugai Pharmaceutical Co Ltd, H1 2019
Pipeline by Exelixis Inc, H1 2019
Pipeline by F. Hoffmann-La Roche Ltd, H1 2019
Pipeline by Handok Inc, H1 2019
Pipeline by MimeTech Srl, H1 2019
Pipeline by Otonomy Inc, H1 2019
Pipeline by Takeda Pharmaceutical Co Ltd, H1 2019
Pipeline by Zebra Biologics Inc, H1 2019
Dormant Products, H1 2019
Dormant Products, H1 2019 (Contd..1), H1 2019
Discontinued Products, H1 2019